| Lee, Jong Mog |
| Recruiting | 4 | 3944 | RoW | aspirin, clopidogrel, prasugrel, ticagrelor | Asan Medical Center | Coronary Artery Disease | 08/27 | 12/28 | | |
NCT04497142: Effect of Perampanel on Peritumoral Hyperexcitability in HGG |
|
|
| Completed | 1/2 | 12 | US | Perampanel, E2007, Fycompa, Standard of Care, Standard treatment (typically the anti-seizure medication levetiracetam) | Dana-Farber Cancer Institute, National Cancer Institute (NCI), Eisai Inc. | Glioma, Malignant, Surgery, Seizures | 05/23 | 05/23 | | |
NCT04409080 / 2020-002031-29: REGN7257 in Adult Patients With Severe Aplastic Anemia That Is Refractory to or Relapsed on Immunosuppressive Therapy |
|
|
| Suspended | 1/2 | 33 | Europe, US, RoW | REGN7257 | Regeneron Pharmaceuticals, Regeneron Pharmaceuticals, Inc | Severe Aplastic Anemia (SAA) | 01/26 | 07/26 | | |
| Not yet recruiting | 1 | 10 | US | Cenobamate | Brigham and Women's Hospital | Epilepsy, Neurologic Disorder | 12/24 | 06/25 | | |
ASSURE, NCT03306901: Chemoradiotherapy Versus Esophagectomy After Endoscopic Resection for Superficial Esophageal Squamous Cell Carcinoma |
|
|
| Active, not recruiting | N/A | 240 | RoW | Esophagectomy, 5-fluorouracil, 5-FU, Cisplatin, Radiation therapy | Samsung Medical Center, Ministry of Health & Welfare, Korea | Esophageal Cancer | 12/25 | 12/33 | | |
ICARUS, NCT05805280: IntravasCular Imaging-Guided Versus AngiogRaphy-GUided Drug-Eluting Stent Implantation for Fermoropopliteal Artery Disease |
|
|
| Recruiting | N/A | 100 | RoW | intravascular ultrasound-guided group, angiography-guided group | Asan Medical Center | Femoropopliteal Disease | 12/24 | 12/25 | | |
| Not yet recruiting | N/A | 10 | US | Control subjects | Brigham and Women's Hospital | Epilepsy | 06/27 | 06/27 | | |
| Recruiting | N/A | 1800 | US | Therapeutic Hypothermia | University of Michigan, Johns Hopkins University, Medical University of South Carolina, National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS) | Cardiac Arrest, Out-Of-Hospital, Hypothermia, Induced, Hypoxia-Ischemia, Brain | 07/28 | 08/28 | | |
| Ahn, Joong B |
NCT04810585: Plasma Biomarker for Aflibercept in Advanced Colorectal Cancer |
|
|
| Recruiting | 4 | 153 | RoW | Aflibercept + FOLFIRI | Yonsei University | Recurrent or Metastatic Colorectal Cancer | 10/25 | 10/25 | | |
| Completed | 3 | 806 | Europe, Canada, US, RoW | Placebo, Mepolizumab | GlaxoSmithKline, PPD DEVELOPMENT, LP | Pulmonary Disease, Chronic Obstructive | 08/24 | 08/24 | | |
|
|
|
|
|
NCT05103020: Phase II Study Comparing Conversion Rate to Surgery With Hepatic Arterial Infusion Chemotherapy to Systemic Chemotherapy in Patients With Non Resectable Liver-only Colorectal Metastases |
|
|
| Recruiting | 2 | 100 | RoW | intra-arterial oxaliplatin + Systemic FOLFIRI + target agent (bevacizumab or cetuximab) every 2 weeks, IV FOLFIRI+ target agent (bevacizumab or cetuximab) every 2 weeks | Yonsei University | Metastatic Colorectal Cancer | 03/23 | 03/25 | | |
NCT03641976: A Study of Bevacizumab, Infusional Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan (A-FOLFOXIRI) Compared With Bevacizumab, Infusional Fluorouracil, Leucovorin, and Irinotecan/Oxaliplatin (A-FOLFIRI/FOLFOX) as First-line Treatment for Metastatic Right-sided Colon Cancer |
|
|
| Recruiting | 2 | 120 | RoW | A-FOLFOXIRI, Arm II (A-FOLFOX/A-FOLFIRI) | Yonsei University | Unresectable Metastatic Right-sided Colon Cancer Starting First-line Combination Chemotherapy, Unresectable Metastatic Right-sided Colon Cancer, Stage IV | 06/24 | 06/24 | | |
TANGO, NCT06029595: Efficacy and Safety of Tanimilast in Asthmatics uNcontrolled on ICS-containinG backgrOund Maintenance Therapy |
|
|
| Recruiting | 2 | 464 | Europe, RoW | Experimental: CHF6001 3200 μg, Placebo Comparator: CHF6001 Placebo | Chiesi Farmaceutici S.p.A. | Uncontrolled Asthma | 12/25 | 12/25 | | |
NCT03286738: Pattern of Use of Bevacizumab or Cetuximab + FOLFIRI Regimen as First-line Treatment in Metastatic Colorectal Cancer |
|
|
| Recruiting | N/A | 1800 | RoW | FOLFIRI, target agent | Joong Bae Ahn | Metastatic Colorectal Cancer | 12/21 | 12/21 | | |
| Chang, Hyuk-Jae |
NCT05939258: Data Acquisition for Connected Network for EMSs Comprehensive Technical-support Using Artificial Intelligence |
|
|
| Completed | N/A | 15296 | RoW | | Yonsei University | Emergency Patients Being Transported by Rescue Ambulance | 12/21 | 12/21 | | |
NCT04829279: Evaluation of Effectiveness for Connected Network for EMS Comprehensive Technical-support Using Artificial Intelligence (CONNECT-AI) System by Community Intervention |
|
|
| Completed | N/A | 15392 | RoW | CONNECT AI system group | Yonsei University | Emergency Patient Transported by Ambulance | 12/21 | 12/21 | | |
PARADIGM, NCT02803411: Progression of AtheRosclerotic PlAque DetermIned by Computed TomoGraphic Angiography Imaging |
|
|
| Active, not recruiting | N/A | 2000 | NA | | Yonsei University, Montreal Heart Institute, Hospital da Luz, Portugal, University of California, Los Angeles, Centro Cardiologico Monzino, University of British Columbia, German Heart Institute, National Institute of Cardiology, Laranjeiras, Brazil, Weill Medical College of Cornell University, Cedars-Sinai Medical Center | Coronary Heart Disease | 01/26 | 01/26 | | |
NCT05108168: Analysis of Clinical featuRes and Echocardiographic Characteristics for Diagnosis of Infiltrative cardiomyopaThy (ACREDIT): Retrospective Multi-center Observational Study |
|
|
| Recruiting | N/A | 500 | RoW | | Yonsei University | Infiltrative Cardiomyopathy | 12/21 | 12/21 | | |
| Hwang, Sunjin |
MP-VAC-206, NCT06219733: Vactosertib and Imatinib Combination in Patients with Advanced Desmoid Tumor/aggressive Fibromatosis (DT/AF) |
|
|
| Withdrawn | 2 | 76 | RoW | Vactosertib, Imatinib | MedPacto, Inc. | Dermoid | 05/22 | 05/22 | | |
| Active, not recruiting | 1/2 | 120 | RoW | TEW-7197, vactosertib | MedPacto, Inc., Merck Sharp & Dohme LLC | Metastatic Colorectal Cancer, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma | 05/24 | 01/25 | | |
NCT03698825: TEW-7197 with Paclitaxel for the Treatment of Metastatic Gastric Cancer |
|
|
| Completed | 1/2 | 62 | RoW | TEW-7197, vactosertib | MedPacto, Inc. | Metastatic Gastric Cancer | 01/22 | 12/22 | | |
| Active, not recruiting | 1/2 | 60 | RoW | TEW-7197, vactosetib | MedPacto, Inc., AstraZeneca | Non-Small Cell Lung Cancer Metastatic | 05/24 | 12/24 | | |
| Lee, Jiyeon |
NCT04407013: Enhanced Supportive Care for Advanced Cancer Patients: Evaluation of Standardized Care Pathway |
|
|
| Recruiting | N/A | 780 | RoW | Enhanced supportive care based on standardized care pathway, Control group with usual care | Yonsei University | Advanced Cancer | 02/24 | 02/24 | | |
| Recruiting | N/A | 104 | US | Sentence training | Purdue University, Temple University, University of California, San Diego | Aphasia | 05/26 | 05/26 | | |
